University of Michigan researchers have determined how a gene that is known to be defective in Down syndrome is regulated and how its dysregulation may lead to neurological defects, providing insights into potential therapeutic ...
Jun 5, 2013
0
0
(Medical Xpress)—A discovery at the University of Virginia School of Medicine is opening up new avenues for treating peripheral arterial disease, a common circulation problem that afflicts millions of Americans. Researchers ...
Jun 4, 2013
0
0
A multi-institutional team of researchers have pinpointed the genetic traits of the cells that give rise to gliomas – the most common form of malignant brain cancer. The findings, which appear in the journal Cell Reports, ...
Jun 3, 2013
0
0
The human immune system is remarkably efficient, but sometimes its attack is misdirected, leading to allergies, autoimmune diseases and rejection of transplant organs and therapeutic drugs. Current immune suppressants have ...
Jun 3, 2013
0
0
A study led by Boston University School of Medicine has identified a novel approach to create an unlimited number of human red blood cells and platelets in vitro. In collaboration with Boston University School of Public Health ...
May 30, 2013
1
0
(HealthDay)—Women appear to have a natural defense against the world's most common sexually transmitted infection, a new study says.
May 30, 2013
0
0
Procedures like angioplasty, stenting and bypass surgery may save lives, but they also cause excessive inflammation and scarring, which ultimately can lead to permanent disability and even death. A new research report appearing ...
May 30, 2013
0
0
Stent angioplasty saves lives, but there often are side effects and complications related to the procedure, such as arterial restenosis and thrombosis. In the June 2013 issue of The FASEB Journal, however, scientists report ...
May 30, 2013
0
0
A team of UT Arlington researchers has identified two ruthenium-based complexes they believe could pave the way for treatments that control cancer cell growth more effectively and are less toxic for patients than current ...
May 28, 2013
0
0
A new study on prostate cancer describes a novel class of drugs developed by UT Southwestern Medical Center researchers that interrupts critical signaling needed for prostate cancer cells to grow.
May 28, 2013
0
0
